Neuropathic pain and spinal microglia: A big problem from molecules in 'small' glia

Trends in Neurosciences

Volumn 28, Issue 2, 2005, Pages 101-107

  Tsuda, Makoto ^a,b   Inoue, Kazuhide ^a,c   Salter, Michael W ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PURINE P2X4 RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLODYNIA; CANCER; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; DIABETES MELLITUS; HUMAN; HYPERSENSITIVITY; MICROGLIA; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN;

ANIMALS; HUMANS; MICROGLIA; MODELS, BIOLOGICAL; NEURALGIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, CHEMOKINE; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 13144276331     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2004.12.002     Document Type: Review

References (70)

1. C.J. Woolf, and M.W. Salter Neuronal plasticity: increasing the gain in pain Science 288 2000 1765 1769
2. J. Scholz, and C.J. Woolf Can we conquer pain? Nat. Neurosci. 5 Suppl 2002 1062 1067
3. M. Zimmermann Pathobiology of neuropathic pain Eur. J. Pharmacol. 429 2001 23 37
4. C.J. Woolf Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy Life Sci. 74 2004 2605 2610
5. L.R. Watkins Glial activation: a driving force for pathological pain Trends Neurosci. 24 2001 450 455
6. L.R. Watkins Spinal cord glia: new players in pain Pain 93 2001 201 205
7. L.R. Watkins, and S.F. Maier GLIA: A novel drug discovery target for clinical pain Nat. Rev. Drug Discov. 2 2003 973 985
8. G.W. Kreutzberg Microglia: a sensor for pathological events in the CNS Trends Neurosci. 19 1996 312 318
9. G. Stoll, and S. Jander The role of microglia and macrophages in the pathophysiology of the CNS Prog. Neurobiol. 58 1999 233 247
10. K. Nakajima, and S. Kohsaka Microglia: activation and their significance in the central nervous system J. Biochem. (Tokyo) 130 2001 169 175
11. V.H. Perry Modulation of microglia phenotype Neuropathol. Appl. Neurobiol. 20 1994 177
12. W.J. Streit Reactive microgliosis Prog. Neurobiol. 57 1999 563 581
13. M.R. Ehlers CR3: a general purpose adhesion-recognition receptor essential for innate immunity Microbes Infect. 2 2000 289 294
14. A.P. Robinson Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3 Immunology 57 1986 239 247
15. U.K. Hanisch Microglia as a source and target of cytokines Glia 40 2002 140 155
16. P.D. Wall Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa Pain 7 1979 103 111
17. G.J. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
18. Z. Seltzer A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury Pain 43 1990 205 218
19. S.H. Kim, and J.M. Chung An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 1992 355 363
20. I. Decosterd, and C.J. Woolf Spared nerve injury: an animal model of persistent peripheral neuropathic pain Pain 87 2000 149 158
21. N.P. Eriksson A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat Exp. Brain Res. 96 1993 19 27
22. L. Liu Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat Neuroscience 68 1995 167 179
23. D.E. Coyle Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior Glia 23 1998 75 83
24. F.Y. Tanga Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain Neurochem. Int. 45 2004 397 407
25. R.W. Colburn Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat J. Neuroimmunol. 79 1997 163 175
26. R.W. Colburn The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior Exp. Neurol. 157 1999 289 304
27. J. Gehrmann, and R.B. Banati Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury J. Neuropathol. Exp. Neurol. 54 1995 680 688
28. V. Raghavendra Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy J. Pharmacol. Exp. Ther. 306 2003 624 630
29. S.M. Sweitzer The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents J. Neuroimmunol. 125 2002 82 93
30. S.M. Sweitzer, and J.A. DeLeo The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model J. Pain 3 2002 360 368
31. G.M. Verge Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions Eur. J. Neurosci. 20 2004 1150 1160
32. A. Nishiyori Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 429 1998 167 172
33. J.K. Harrison Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia Proc. Natl. Acad. Sci. U. S. A. 95 1998 10896 10901
34. R. Kalla Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice J. Comp. Neurol. 436 2001 182 201
35. M.A. Klein Impaired neuroglial activation in interleukin-6 deficient mice Glia 19 1997 227 233
36. R.M. Hoek Down-regulation of the macrophage lineage through interaction with OX2 (CD200) Science 290 2000 1768 1771
37. C.I. Svensson Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing J. Neurochem. 86 2003 1534 1544
38. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature 424 2003 778 783
39. S.X. Jin p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain J. Neurosci. 23 2003 4017 4022
40. M. Tsuda Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury Glia 45 2004 89 95
41. V. Ralevic, and G. Burnstock Receptors for purines and pyrimidines Pharmacol. Rev. 50 1998 413 492
42. B.S. Khakh International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits Pharmacol. Rev. 53 2001 107 118
43. C. Kennedy Crossing the pain barrier: P2 receptors as targets for novel analgesics J. Physiol. 553 2003 683 694
44. K. Ono, and J. Han The p38 signal transduction pathway: activation and function Cell. Signal. 12 2000 1 13
45. M. Schafers Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons J. Neurosci. 23 2003 2517 2521
46. P.B. Tran, and R.J. Miller Chemokine receptors: signposts to brain development and disease Nat. Rev. Neurosci. 4 2003 444 455
47. C. Abbadie Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Proc. Natl. Acad. Sci. U. S. A. 100 2003 7947 7952
48. 2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models Eur. J. Neurosci. 17 2003 2750 2754
49. B.F. Cravatt, and A.H. Lichtman The endogenous cannabinoid system and its role in nociceptive behavior J. Neurobiol. 61 2004 149 160
50. A. Devitt Human CD14 mediates recognition and phagocytosis of apoptotic cells Nature 392 1998 505 509
51. H. Aldskogius, and E.N. Kozlova Central neuron-glial and glial-glial interactions following axon injury Prog. Neurobiol. 55 1998 1 26
52. M.J. Carson Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis Glia 40 2002 218 231
53. P. Eikelenboom Neuroinflammation in Alzheimer's disease and prion disease Glia 40 2002 232 239
54. G.A. Garden Microglia in human immunodeficiency virus-associated neurodegeneration Glia 40 2002 240 251
55. R.B. Banati Visualising microglial activation in vivo Glia 40 2002 206 217
56. S. Visentin Two different ionotropic receptors are activated by ATP in rat microglia J. Physiol. 519 1999 723 736
57. K. Inoue Microglial activation by purines and pyrimidines Glia 40 2002 156 163
58. 7 receptor-activated microglia J. Neurosci. 24 2004 1 7
59. E.W. Boddeke Cultured rat microglia express functional beta-chemokine receptors J. Neuroimmunol. 98 1999 176 184
60. E. Ambrosini, and F. Aloisi Chemokines and glial cells: a complex network in the central nervous system Neurochem. Res. 29 2004 1017 1038
61. S.M. Sweitzer Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain Pain 100 2002 163 170
62. M. Kerschensteiner Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189 1999 865 870
63. G. Moalem Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity J. Autoimmun. 15 2000 331 345
64. W.J. Streit, and M.B. Graeber Heterogeneity of microglial and perivascular cell populations: insights gained from the facial nucleus paradigm Glia 7 1993 68 74
65. S.M. Sweitzer Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat Brain Res. 829 1999 209 221
66. V. Raghavendra Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS Eur. J. Neurosci. 20 2004 467 473
67. P. Honore Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons Neuroscience 98 2000 585 598
68. J. Wieseler-Frank Glial activation and pathological pain Neurochem. Int. 45 2004 389 395
69. M.M. Backonja Defining neuropathic pain Anesth. Analg. 97 2003 785 790
70. 4 receptor and ischemic cell death: prevention by P2 antagonists Neuroscience 120 2003 85 98